{"id":427,"date":"2019-09-09T12:02:30","date_gmt":"2019-09-09T12:02:30","guid":{"rendered":"http:\/\/events.marketsandmarkets.com\/blog\/?p=427"},"modified":"2019-09-09T12:06:21","modified_gmt":"2019-09-09T12:06:21","slug":"london-september-3-2019-marketsandmarkets-recently-interviewed-dr-susan-astley-division-of-informatics-imaging-data-sciences-university-of-manchester-regarding-marketsandmarkets-biom","status":"publish","type":"post","link":"https:\/\/events.marketsandmarkets.com\/blognew\/london-september-3-2019-marketsandmarkets-recently-interviewed-dr-susan-astley-division-of-informatics-imaging-data-sciences-university-of-manchester-regarding-marketsandmarkets-biom\/","title":{"rendered":"Speaker Interview with Dr. Susan Astley for MarketsandMarkets Biomarker and Companion Diagnostics Conference"},"content":{"rendered":"\n<p><strong>London, September 3, 2019<\/strong> \u2013 MarketsandMarkets recently interviewed <strong>Dr. Susan Astley<\/strong>, Division of Informatics, Imaging &amp; Data Sciences, University of Manchester regarding MarketsandMarkets Biomarker and Companion Diagnostics Conference taking place on <strong>3rd &#8211; 4th October 2019<\/strong> at <strong>Radisson Blu Edwardian, Grafton, London, UK<\/strong><\/p>\n\n\n\n<p><strong>Q. What are the recent advances in Biomarker research\/commercialization and current challenges that need immediate attention?<\/strong><\/p>\n\n\n\n<p><strong>A<\/strong>. <em>The era of personalised medicine is with us. Biomarkers are crucial to identify those at risk of particular diseases, and those who would benefit from different preventative or therapeutic interventions.<\/em><\/p>\n\n\n\n<p><strong>Q. What are the new opportunities emerging in your field of work?<\/strong><\/p>\n\n\n\n<p><em>My field is imaging biomarkers of breast cancer. With a wider spectrum of imaging techniques available, we aim to identify the most appropriate screening regime for an individual, based on personal risk and breast composition.<\/em><\/p>\n\n\n\n<p><strong>Q. What are the key take away points from your presentation topic which will help in building the knowledge base of attendees? <\/strong><\/p>\n\n\n\n<p>A. <em>Imaging has a lot to offer in the biomarker field, and with the advent of large databases of images and other data, AI is a key methodology to advance science.<\/em><\/p>\n\n\n\n<p><strong>Q. Hope you had a chance to go through the agenda, what are your views on it and how helpful it is to the targeted audience? <\/strong><\/p>\n\n\n\n<p>A. <em>I am looking forward to hearing from a diverse range of speakers!<\/em><\/p>\n\n\n\n<p>Dr. Susan Astley will present on Imaging Biomarkers of breast cancer risk<\/p>\n\n\n\n<p>The latest conference agenda and complete speaker line-up is available to download on the conference page, where you can also register \u2013&nbsp;<a href=\"https:\/\/bit.ly\/2lLukmp\" target=\"_blank\" rel=\"noopener\">https:\/\/bit.ly\/2lLukmp<\/a><\/p>\n\n\n\n<p><a href=\"https:\/\/bit.ly\/2LNkgpQ\" target=\"_blank\" rel=\"noopener\"><\/a>For more inquiries contact\u00a0<strong>Amit Shelke<\/strong>, Marketing Manager on\u00a0<a href=\"mailto:amit.shelke@marketsandmarkets.com\"><strong>amit.shelke@marketsandmarkets.com<\/strong><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>London, September 3, 2019 \u2013 MarketsandMarkets recently interviewed Dr. Susan Astley, Division of Informatics, Imaging &amp; Data Sciences, University of Manchester regarding MarketsandMarkets Biomarker and Companion Diagnostics Conference taking place on 3rd &#8211; 4th October 2019 at Radisson Blu Edwardian, Grafton, London, UK Q. What are the recent advances in Biomarker research\/commercialization and current challenges [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":428,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"_mi_skip_tracking":false},"categories":[3,5,2],"tags":[161,17,160,159],"_links":{"self":[{"href":"https:\/\/events.marketsandmarkets.com\/blognew\/wp-json\/wp\/v2\/posts\/427"}],"collection":[{"href":"https:\/\/events.marketsandmarkets.com\/blognew\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/events.marketsandmarkets.com\/blognew\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/events.marketsandmarkets.com\/blognew\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/events.marketsandmarkets.com\/blognew\/wp-json\/wp\/v2\/comments?post=427"}],"version-history":[{"count":2,"href":"https:\/\/events.marketsandmarkets.com\/blognew\/wp-json\/wp\/v2\/posts\/427\/revisions"}],"predecessor-version":[{"id":431,"href":"https:\/\/events.marketsandmarkets.com\/blognew\/wp-json\/wp\/v2\/posts\/427\/revisions\/431"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/events.marketsandmarkets.com\/blognew\/wp-json\/wp\/v2\/media\/428"}],"wp:attachment":[{"href":"https:\/\/events.marketsandmarkets.com\/blognew\/wp-json\/wp\/v2\/media?parent=427"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/events.marketsandmarkets.com\/blognew\/wp-json\/wp\/v2\/categories?post=427"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/events.marketsandmarkets.com\/blognew\/wp-json\/wp\/v2\/tags?post=427"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}